• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

槲皮素通过激活 p53,以不依赖 HPV-E6 表达的方式诱导 HPV 阳性人宫颈癌源性细胞发生 G2 期阻滞和凋亡。

Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression‑independent manner in HPV‑positive human cervical cancer‑derived cells.

机构信息

Faculty of Pharmacy, Autonomous University of Morelos State (UAEM), Cuernavaca, Morelos CP 62209, México.

Department of Developmental Genetics and Molecular Physiology, National Autonomous University of Mexico, Cuernavaca, Morelos, CP 62210, México.

出版信息

Mol Med Rep. 2019 Mar;19(3):2097-2106. doi: 10.3892/mmr.2019.9850. Epub 2019 Jan 11.

DOI:10.3892/mmr.2019.9850
PMID:30664221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6390007/
Abstract

Cervical cancer is the second most common cancer in women worldwide. Human papillomavirus (HPV) infection appears to be a necessary factor in the development of almost all cases (>95%) of cervical cancer. HPV E6 induces a change of control of p53 stabilization from Hdm2 to E6/E6AP in HPV‑infected cells. It is well known that the LxxLL motif of cellular ubiquitin ligase E6AP binds to the pocket of E6 and causes a conformational change to enable E6 to bind p53 competently. In the ternary complex E6/E6AP/p53, p53 is polyubiquitinated by E6AP and subsequently degraded by a proteasome. Therefore, these cells are deficient in the processes regulated by p53, including apoptosis, damaged DNA repair, and the cell cycle. In the present study, it was demonstrated that quercetin induced G2 phase cell cycle arrest and apoptosis in both HeLa and SiHa cells, accompanied by an increase of p53 and its nuclear signal. It was also observed that quercetin increased the level of the p21 transcript and the pro‑apoptotic Bax protein, which are two p53‑downstream effectors. However, quercetin did not alter the expression of the HPV E6 protein in cervical cancer cells; therefore, the increase in p53 occurred in an E6 expression‑independent manner. Furthermore, molecular docking demonstrated that quercetin binds stably in the central pocket of E6, the binding site of E6AP. These data suggest that quercetin increases the nuclear localization of p53 by interrupting E6/E6AP complex formation in cervical cancer cells.

摘要

宫颈癌是全球女性中第二常见的癌症。人乳头瘤病毒(HPV)感染似乎是几乎所有宫颈癌病例(>95%)发展的必要因素。HPV E6 诱导 HPV 感染细胞中 p53 稳定性控制从 Hdm2 向 E6/E6AP 的改变。众所周知,细胞泛素连接酶 E6AP 的 LxxLL 基序与 E6 的口袋结合,导致构象变化,使 E6 能够有效地与 p53 结合。在三元复合物 E6/E6AP/p53 中,E6AP 使 p53 多泛素化,随后被蛋白酶体降解。因此,这些细胞缺乏受 p53 调节的过程,包括细胞凋亡、受损的 DNA 修复和细胞周期。在本研究中,证明了槲皮素诱导 HeLa 和 SiHa 细胞的 G2 期细胞周期停滞和细胞凋亡,同时 p53 及其核信号增加。还观察到槲皮素增加了 p21 转录本和促凋亡 Bax 蛋白的水平,这是 p53 的两个下游效应物。然而,槲皮素并未改变宫颈癌细胞中 HPV E6 蛋白的表达;因此,p53 的增加是在 E6 表达不依赖的方式下发生的。此外,分子对接表明,槲皮素通过中断宫颈癌细胞中 E6/E6AP 复合物的形成,稳定地结合在 E6 的中央口袋中,即 E6AP 的结合位点。这些数据表明,槲皮素通过中断 E6/E6AP 复合物的形成,增加了宫颈癌细胞中 p53 的核定位。

相似文献

1
Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression‑independent manner in HPV‑positive human cervical cancer‑derived cells.槲皮素通过激活 p53,以不依赖 HPV-E6 表达的方式诱导 HPV 阳性人宫颈癌源性细胞发生 G2 期阻滞和凋亡。
Mol Med Rep. 2019 Mar;19(3):2097-2106. doi: 10.3892/mmr.2019.9850. Epub 2019 Jan 11.
2
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.人乳头瘤病毒介导的p53降解所需的E6/E6相关蛋白/p53复合物的结构
Nature. 2016 Jan 28;529(7587):541-5. doi: 10.1038/nature16481. Epub 2016 Jan 20.
3
Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.丹参酮 IIA 通过抑制病毒癌基因表达诱导宫颈癌凋亡。
Cancer Lett. 2015 Jan 28;356(2 Pt B):536-46. doi: 10.1016/j.canlet.2014.09.037. Epub 2014 Oct 7.
4
Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.E6AP(UBE3A)的多个区域有助于与乳头瘤病毒 E6 蛋白相互作用,并激活泛素连接酶活性。
PLoS Pathog. 2020 Jan 23;16(1):e1008295. doi: 10.1371/journal.ppat.1008295. eCollection 2020 Jan.
5
Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.基于结构的破坏人乳头瘤病毒16型E6功能的黄酮类化合物的鉴定与表征
PLoS One. 2013 Dec 23;8(12):e84506. doi: 10.1371/journal.pone.0084506. eCollection 2013.
6
Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.高危型人乳头瘤病毒 31 型 E6 致癌蛋白的结构与 E6/E6AP/p53 复合物形成的鉴定。
J Virol. 2020 Dec 22;95(2). doi: 10.1128/JVI.00730-20.
7
E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.高危型 HPV、低危型 HPV 和动物乳头瘤病毒的 E6 蛋白通过 E6AP 依赖性降解 NHERF1 激活 Wnt/β-连环蛋白通路。
PLoS Pathog. 2019 Apr 19;15(4):e1007575. doi: 10.1371/journal.ppat.1007575. eCollection 2019 Apr.
8
Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6.激活转录因子 3 通过阻止 E6 相关蛋白与 E6 结合来激活 p53。
J Biol Chem. 2010 Apr 23;285(17):13201-10. doi: 10.1074/jbc.M109.058669. Epub 2010 Feb 18.
9
A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.单密码子突变可将人乳头瘤病毒16型(HPV16)E6癌蛋白转化为一种潜在的肿瘤抑制因子,该因子可诱导HPV阳性的人宫颈癌HeLa细胞发生p53依赖性衰老。
Oncogene. 2009 Feb 5;28(5):762-72. doi: 10.1038/onc.2008.422. Epub 2008 Nov 17.
10
The E6AP binding pocket of the HPV16 E6 oncoprotein provides a docking site for a small inhibitory peptide unrelated to E6AP, indicating druggability of E6.人乳头瘤病毒16型E6癌蛋白的E6AP结合口袋为一种与E6AP无关的小抑制肽提供了一个对接位点,这表明E6具有可成药性。
PLoS One. 2014 Nov 10;9(11):e112514. doi: 10.1371/journal.pone.0112514. eCollection 2014.

引用本文的文献

1
Antiproliferative and Anti-Migratory Activities of an Extract from Leaves and Its Molecular Profile.叶片提取物的抗增殖和抗迁移活性及其分子特征
Plants (Basel). 2025 Aug 28;14(17):2693. doi: 10.3390/plants14172693.
2
Mechanism of action of against human papillomavirus-positive head and neck squamous cell carcinoma.[具体药物名称]对人乳头瘤病毒阳性头颈部鳞状细胞癌的作用机制
Oncol Lett. 2025 Aug 11;30(4):475. doi: 10.3892/ol.2025.15221. eCollection 2025 Oct.
3
A Narrative Review of Quercetin's Role as a Bioactive Compound in Female Reproductive Disorders.

本文引用的文献

1
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.宫颈癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv72-iv83. doi: 10.1093/annonc/mdx220.
2
Quercetin, a Natural Flavonoid Interacts with DNA, Arrests Cell Cycle and Causes Tumor Regression by Activating Mitochondrial Pathway of Apoptosis.槲皮素,一种天然黄酮类化合物,与DNA相互作用,通过激活线粒体凋亡途径阻滞细胞周期并导致肿瘤消退。
Sci Rep. 2016 Apr 12;6:24049. doi: 10.1038/srep24049.
3
The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression.
槲皮素作为生物活性化合物在女性生殖系统疾病中作用的叙述性综述
Nutrients. 2025 Mar 24;17(7):1118. doi: 10.3390/nu17071118.
4
Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical Studies.癌症化学预防中的植物化学物质:临床前和临床研究
Cancer Control. 2024 Jan-Dec;31:10732748241302902. doi: 10.1177/10732748241302902.
5
Cytotoxicity, Proapoptotic Activity and Drug-like Potential of Quercetin and Kaempferol in Glioblastoma Cells: Preclinical Insights.槲皮素和山柰酚对神经胶质瘤细胞的细胞毒性、促凋亡活性和类药性潜力:临床前见解。
Int J Mol Sci. 2024 Oct 5;25(19):10740. doi: 10.3390/ijms251910740.
6
Potential mechanisms of ZiGongDing in treating HPV-induced cervical intraepithelial neoplasia: a network pharmacology and experimental verification study.紫宫定治疗人乳头瘤病毒诱导的宫颈上皮内瘤变的潜在机制:一项网络药理学及实验验证研究
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):3027-3036. doi: 10.1007/s00210-024-03445-5. Epub 2024 Sep 26.
7
An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence.胶质瘤尚未开发的机遇之窗:在复发前靶向治疗诱导的衰老。
NPJ Precis Oncol. 2023 Nov 29;7(1):126. doi: 10.1038/s41698-023-00476-8.
8
Polyphenol-Based Nanoparticles: A Promising Frontier for Enhanced Colorectal Cancer Treatment.基于多酚的纳米颗粒:增强结直肠癌治疗的一个有前景的前沿领域。
Cancers (Basel). 2023 Jul 27;15(15):3826. doi: 10.3390/cancers15153826.
9
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021.小分子人乳头瘤病毒抑制剂:1997 年至 2021 年研究综述。
Curr Med Chem. 2024;31(33):5308-5350. doi: 10.2174/0929867331666230713165407.
10
Potentiation of Cisplatin Cytotoxicity in Resistant Ovarian Cancer SKOV3/Cisplatin Cells by Quercetin Pre-Treatment.槲皮素预处理增强耐药卵巢癌细胞 SKOV3/顺铂细胞中的顺铂细胞毒性。
Int J Mol Sci. 2023 Jun 30;24(13):10960. doi: 10.3390/ijms241310960.
p53在肿瘤起始和进展中的细胞周期阻滞及凋亡功能
Cold Spring Harb Perspect Med. 2016 Mar 1;6(3):a026104. doi: 10.1101/cshperspect.a026104.
4
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.人乳头瘤病毒介导的p53降解所需的E6/E6相关蛋白/p53复合物的结构
Nature. 2016 Jan 28;529(7587):541-5. doi: 10.1038/nature16481. Epub 2016 Jan 20.
5
Identification and characterization of small molecule human papillomavirus E6 inhibitors.鉴定和表征小分子人乳头瘤病毒 E6 抑制剂。
ACS Chem Biol. 2014 Jul 18;9(7):1603-12. doi: 10.1021/cb500229d. Epub 2014 Jun 2.
6
Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.基于结构的破坏人乳头瘤病毒16型E6功能的黄酮类化合物的鉴定与表征
PLoS One. 2013 Dec 23;8(12):e84506. doi: 10.1371/journal.pone.0084506. eCollection 2013.
7
Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.估计人乳头瘤病毒疫苗接种对宫颈癌病例和死亡人数的潜在总体影响。
Vaccine. 2014 Feb 3;32(6):733-9. doi: 10.1016/j.vaccine.2013.11.049. Epub 2013 Nov 26.
8
Screening for cervical cancer: a systematic review and meta-analysis.宫颈癌筛查:系统评价和荟萃分析。
Syst Rev. 2013 May 24;2:35. doi: 10.1186/2046-4053-2-35.
9
Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.细胞 LxxLL 基序被乳头瘤病毒 E6 癌蛋白劫持的结构基础。
Science. 2013 Feb 8;339(6120):694-8. doi: 10.1126/science.1229934.
10
Peptide interactions stabilize and restructure human papillomavirus type 16 E6 to interact with p53.肽相互作用稳定并重构人乳头瘤病毒 16 型 E6 以与 p53 相互作用。
J Virol. 2012 Oct;86(20):11386-91. doi: 10.1128/JVI.01236-12. Epub 2012 Aug 15.